Geoffrey Martha - 01 Aug 2025 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: Chairman and CEO, Director
Issuer ticker: MDT
Reported as of: 01 Aug 2025
Net transaction value: -$3,728,014
SEC form: 4
Accepted by SEC: 04 Aug 2025, 16:18:46 UTC
Prior SEC filing: 30 Jul 2025
Next SEC filing: 17 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Geoffrey Martha filed Form 4 for Medtronic plc (MDT) on 04 Aug 2025.

Key facts

This page summarizes Geoffrey Martha's Form 4 filing for Medtronic plc (MDT).
7 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Aug 2025, 16:18.

Change

Previous filing in this sequence was filed on 30 Jul 2025.
Current net transaction value: -$3,728,014.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001560409 Primary reporting owner

Martha Geoffrey

Relationship: Chairman and CEO, Director
Address: 710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature: /s/ Patricia Walesiewicz, attorney-in-fact
Signature date: 04 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Options Exercise

Transaction value: $0
Shares: +57,724
Change %: +26%
Price: $0.000000
Shares after: 283,700
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F1

MDT transaction

Ordinary Shares

Tax liability

Transaction value: $2,351,697
Shares: -26,323
Change %: -9.3%
Price: $89.34
Shares after: 257,377
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F2

MDT transaction

Ordinary Shares

Tax liability

Transaction value: $1,166,244
Shares: -13,054
Change %: -5.1%
Price: $89.34
Shares after: 244,323
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F3

MDT transaction

Ordinary Shares

Options Exercise

Transaction value: $3,166,800
Shares: +40,600
Change %: +17%
Price: $78.00
Shares after: 284,923
Date: 01 Aug 2025
Ownership: Direct

MDT transaction

Ordinary Shares

Tax liability

Transaction value: $3,376,873
Shares: -37,798
Change %: -13%
Price: $89.34
Shares after: 247,125
Date: 01 Aug 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Units

Options Exercise

Transaction value: $0
Shares: -57,724
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Aug 2025
Ownership: Direct
Underlying class: Performance Share Unit
Underlying amount: 57,724
Exercise price
Footnotes: F4, F5

MDT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -40,600
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Aug 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 40,600
Exercise price: $78.00
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.

Footnote F2

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.

Footnote F3

Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

Footnote F4

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F5

The performance share units vested on August 1, 2025.

Footnote F6

These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.